Beta-Arbutin (ARBUTIN)
Commonly Found In
Overview
Arbutin is a glycosylated derivative of hydroquinone naturally present in bearberry (Arctostaphylos uva-ursi) leaves and several other plants, widely used as a skin-brightening active in cosmetics. It inhibits tyrosinase activity and may suppress the maturation of melanosomes, thereby reducing melanin production and helping to address hyperpigmentation, including dark spots, melasma, and post-inflammatory discoloration. Clinical evidence suggests arbutin is effective and generally better tolerated than free hydroquinone, as the glucose moiety slows its conversion to hydroquinone and reduces direct cellular toxicity. Japan's MHLW recognizes arbutin as an approved quasi-drug whitening active, reflecting its established safety and efficacy data; the EU permits it in cosmetics at up to 7% in face creams and 2% in body lotions.
Also known as: Beta-Arbutin, Hydroquinone-O-beta-D-glucoside, Hydroquinone beta-D-glucopyranoside, Uva Ursi Extract, p-Hydroxyphenyl beta-D-glucopyranoside
Key Benefits
Clinical evidence indicates arbutin effectively reduces tyrosinase activity and may suppress melanosome maturation, leading to decreased melanin production. Studies suggest it can visibly improve the appearance of hyperpigmentation, dark spots, and uneven skin tone over 8-12 weeks of consistent use. Its hydroquinone precursor activity is considered substantially milder than direct hydroquinone application due to the protective glycoside bond.
Supporting Research
- β’ Sugimoto K et al. (1992). Alpha-arbutin: a safe, highly effective skin-lightening compound with tyrosinase-inhibiting activity. Cosmetics & Toiletries, 107, 77-81. Compared alpha- and beta-arbutin efficacy in tyrosinase inhibition.
- β’ Boo YC (2021). Arbutin as a skin depigmenting agent with antimelanogenic and antioxidant properties. Antioxidants, 10(7), 1129. Comprehensive review of brightening mechanisms and clinical evidence.
- β’ Hamed SH et al. (2010). Comparative efficacy and safety of arbutin on melasma. Journal of Drugs in Dermatology, 9(1), 84-90. Clinical trial demonstrating significant melasma improvement.
Skin Compatibility Ratings
Comedogenic Rating
Non-comedogenic at typical cosmetic concentrations.
Source: Draelos ZD & DiNardo JC (2006). A re-evaluation of the comedogenicity concept. JAAD, 54(3), 507-512.
Irritancy Rating
Generally well tolerated; mild irritation or sensitization possible in a small subset of individuals, particularly at higher concentrations. Considered lower-risk than hydroquinone.
Source: SCCS Opinion and Boo YC (2021). Antioxidants, 10(7), 1129.
Typical Use Concentration
Range
0.3-7%
Optimal
1-4%
EU permits up to 7% in face leave-on products and 2% in body leave-on products per Commission Regulation (EU) 2021/1099. Japan allows as a quasi-drug whitening active. Alpha-arbutin is typically used at lower concentrations (0.5-2%) due to higher potency.
Works Well With / Avoid
Works Well With
Use With Caution
Regular sunscreen use is considered essential alongside arbutin-based brightening treatments to prevent UV-stimulated re-pigmentation. Alpha-arbutin (INCI: ALPHA-ARBUTIN) is a distinct isomer considered more potent and more stable than beta-arbutin.
Commonly Found In
Global Regulation Summary
Overview of current status across major international markets.
Detailed Regional Status
| Region | Status | Max Conc. | Conditions | Source |
|---|---|---|---|---|
| πͺπΊ EU | Unknown | - | - | Official β |
| πΊπΈ USA | Unknown | - | - | Official β |
| π―π΅ Japan | Unknown | - | - | Official β |
| π°π· Korea | Unknown | - | - | Official β |
| π¬π§ UK | Unknown | - | - | Official β |
π Why Regulations Differ
Arbutin's regulatory complexity stems from its structural relationship to hydroquinone, which is banned in cosmetics in many markets. The EU permitted arbutin at defined concentration limits only after specific SCCS safety evaluations confirming that hydroquinone release from beta-arbutin under normal use conditions is within acceptable safety margins. Japan's MHLW approved it as a quasi-drug whitening active with a long regulatory and commercial history. The US does not impose a specific concentration cap, treating it as a cosmetic active under FDA oversight. Alpha-arbutin (a more potent isomer) has separate regulatory considerations in some markets.
Recent Regulatory Changes
- β’ Commission Regulation (EU) 2021/1099 formally restricted arbutin to 7% in face leave-on and 2% in body leave-on products, ending a period without specific EU concentration limits.
- β’ EU SCCS Opinion on arbutin safety assessments considered hydroquinone release kinetics as a key safety parameter.
Regulation Analysis
Category Comparison
97% of SKIN CONDITIONING ingredients (378 of 389) are banned in the EU, but this one is approved.
πΏ Natural Sources
Naturally present in bearberry plant (Arctostaphylos uva-ursi) leaves and bark at 5-16% concentration. Also found in cranberries, blueberries, pears, wheat, and various other plants. Bearberry (uva-ursi) has been used in Western herbal medicine and traditional Chinese medicine for centuries.
π How It's Made
Beta-arbutin extracted from bearberry plants. Synthetic production: reaction of acetobromoglucose and hydroquinone in presence of alkali. Modern methods ensure hydroquinone contamination remains below 1 ppm for safety.
π Uses in Cosmetics
Used in skin brightening products and serums at up to 7% (EU limit for face creams). Works by gradually reducing melanin production, helping to lighten dark spots and even skin tone. A gentler, plant-derived alternative to hydroquinone.
π¬ Other Applications
Traditional use in phytotherapy for treating urinary tract infections. Uva-ursi (bearberry) extracts used in herbal medicine as antibacterial agent. More expensive than traditional skin lightening ingredients but safer than banned hydroquinone.
π‘ Fun Facts
- β’ Bearberry (uva-ursi) has been used in herbal medicine for centuries - the name 'uva-ursi' means 'bear's grape' in Latin
- β’ Traditional Chinese medicine has utilized arbutin-rich herbs for centuries to treat skin conditions before modern cosmetic science isolated the active compound
- β’ More expensive than hydroquinone but safer - became popular after hydroquinone was banned in many countries due to safety concerns
Related Skin Concerns
Data Sources
- β’ Boo YC (2021). Antioxidants, 10(7), 1129.
- β’ Commission Regulation (EU) 2021/1099 on arbutin.
- β’ Hamed SH et al. (2010). Journal of Drugs in Dermatology, 9(1), 84-90.
- β’ MHLW Japan quasi-drug whitening active approvals.
- β’ Draelos ZD & DiNardo JC (2006). JAAD, 54(3), 507-512.
- β’ SCCS safety assessments on arbutin and hydroquinone release.
Last data verification: 2026-04-12
Related Ingredients
Ξ±-Arbutin
ALPHA-ARBUTIN
5-Hydroxy-2-hydroxymethyl-4-pyrone
KOJIC ACID
Nonanedioic Acid
AZELAIC ACID
CANNABIDIOL - DERIVED FROM EXTRACT OR TINCTURE OR RESIN OF CANNABIS
CANNABIDIOL - SYNTHETICALLY PRODUCED
CANNABIS SATIVA FLOWER/LEAF/STEM EXTRACT
Learn More
Frequently Asked Questions
What is ARBUTIN used for in cosmetics?
ARBUTIN is primarily used for skin conditioning in cosmetic products. It also serves as skin brightening, antioxidant. The ingredient is commonly found in moisturizers, lotions, and creams.
Which countries regulate ARBUTIN?
ARBUTIN is approved for cosmetic use in all major markets: , with no significant restrictions.
Where can I find official regulation information about ARBUTIN?
Official information about ARBUTIN regulations can be found on government websites: EU CosIng database, US FDA Cosmetics page, Japan MHLW cosmetics standards, UK Government cosmetics guidance, and Korea MFDS. Always verify regulatory status with these official sources before making formulation decisions.
Disclaimer
The information on this website is for educational and informational purposes only and is not intended as medical advice. While we strive for accuracy based on official government databases, cosmetic regulations change frequently. Always consult with a qualified professional or refer to the latest official regulatory documents for compliance. We are not responsible for any actions taken based on the information provided here.